Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Frontiers in Immunology, 2024
Vitreous Olink proteomics reveals inflammatory biomarkers for diagnosis and prognosis of traumatic proliferative vitreoretinopathy

Guo H., Wang T., Yu J. et al.

Olink Target 96OphthalmologyPatient StratificationVitreous

Frontiers in Immunology, 2024
Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19

Baranova A., Luo J., Fu L. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Nature Communications, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancer

Blanco-Heredia J., Souza C., Trincado J. et al.

Olink Target 96OncologyPathophysiologyPlasmaSerumTissue Lysate

Molecular Cancer, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

Toulmonde M., Guegan J., Spalato-Ceruso M. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Acta Biomaterialia, 2024
Increased matrix stiffness enhances pro-tumorigenic traits in a physiologically relevant breast tissue- monocyte 3D model

Abrahamsson A., Boroojeni F., Naeimipour S. et al.

Olink Target 96OncologyTechnical EvaluationMicrodialysis Fluid

Annals of the Rheumatic Diseases, 2024
Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker

Ea H., Kischkel B., Chirayath T. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Dermatology and Therapy, 2024
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Ludbrook V., Budd D., Thorn K. et al.

Olink Target 96Dermatological DiseasesPathophysiologyPlasma

Journal of Autoimmunity, 2024
The enigma of sclera-specific autoimmunity in scleritis

Vergouwen D., van Beek A., de Hoog J. et al.

Olink Explore 3072/384OphthalmologyPathophysiologySerum

Computers in Biology and Medicine, 2024
Exploring metformin monotherapy response in Type-2 diabetes: Computational insights through clinical, genomic, and proteomic markers using machine learning algorithms

Villikudathil A., Mc Guigan D., English A.

Olink Target 96Metabolic DiseasesPatient StratificationBlood

Advances in Rheumatology, 2024
Inflammatory cytokines and their potential role in Sjogren’s syndrome risk: insights from a mendelian randomization study

Shi W., Xu Y., Zhang A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Cardiovascular Diabetology, 2024
Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes

Gurung R., Liu S., Liu J. et al.

Olink Target 96CVDPatient StratificationPlasma

Frontiers in Immunology, 2024
Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

Cuesta-López L., Escudero-Contreras A., Hanaee Y. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Mechanisms of Ageing and Development, 2024
Common and distinct metabolomic markers related to immune aging in Western European and East African populations

Bulut O., Temba G., Koeken V. et al.

Olink Target 96AgingPathophysiologyPlasma

Molecular Metabolism, 2024
Intermittent rapamycin feeding recapitulates some effects of continuous treatment while maintaining lifespan extension

Baghdadi M., Nespital T., Monzó C. et al.

Olink Target 96 MouseAgingPathophysiologyPlasma

BMC Cardiovascular Disorders, 2024
Association between C10X polymorphism in the CARD8 gene and inflammatory markers in young healthy individuals in the LBA study

Fransén K., Hiyoshi A., Paramel G. et al.

Olink Target 96CVDPathophysiologyPlasma

Journal of Inflammation Research, 2024
Inflammation and Neurodegeneration in Glaucoma: Isolated Eye Disease or a Part of a Systemic Disorder? - Serum Proteomic Analysis

Okruszko M., Szabłowski M., Zarzecki M. et al.

Olink Target 96OphthalmologyPathophysiologyPlasma

Nature Aging, 2024
Plasma proteomic profiles predict future dementia in healthy adults

Guo Y., You J., Zhang Y. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Nature Cardiovascular Research, 2024
Markers of imminent myocardial infarction

Gustafsson S., Lampa E., Jensevik Eriksson K. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Ecotoxicology and Environmental Safety, 2024
Perinatal exposure to PFOS and sustained high-fat diet promote neurodevelopmental disorders via genomic reprogramming of pathways associated with neuromotor development

Hmila I., Hill J., Shalaby K. et al.

Olink Target 96 MouseNeurologyEnvironmental Health & ToxicologyPathophysiologyTissue Lysate

Neoplasia, 2024
A liquid biomarker signature of inflammatory proteins accurately predicts early pancreatic cancer progression during FOLFIRINOX chemotherapy

van Eijck C., Sabroso-Lasa S., Strijk G. et al.

Olink Explore 3072/384OncologyPatient StratificationSerum

2821 publications